4th Quarter - Report
SOLUGEN INC for SOLUGEN INC
Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Support the use of bio-based chemicals in the Department of Defense, generally. Department of Defense Appropriations Act, 2026 (H.R.4016/ S.2572 - 119th Congress). National Defense Authorization Act for Fiscal Year 2026 (S.2296 - 119th Congress).
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY HOLBROOK | — |
| BRYAN J. SOUKUP | — |
Environment/Superfund ENV
Educate policymakers about Solugen's technology to produce bio-based chemicals, generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY HOLBROOK | — |
| BRYAN J. SOUKUP | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.